Melvin Chua

Associate Professor

Duke-NUS Medical School

Singapore

Research Interests

Explore related searches

Professors in Medical Imaging

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (2)

Keunchil Park

Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Daniel E Spratt

University Hospitals Seidman Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Melvin Chua

Research Interests

Explore related searches

Contact this professor

Articles (15)

Use of Natural Language Processing to Infer Sites of Metastatic Disease From Radiology Reports at Scale

Management of advanced prostate cancer in the Asia‐Pacific region: Summary of the Asia‐Pacific Advanced Prostate Cancer Consensus Conference 2023

Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and Borders

ASCO's Leadership Development Program: Focusing on the Next Generation of Leaders in Asia Pacific

A Review of the Current Clinical Evidence for Loco-Regional Moderate Hyperthermia in the Adjunct Management of Cancers

Stochastic Stomatitis: Radiation Recall Reactions in the Era of Immune Checkpoint Blockade

A novel prostate cancer subtyping classifier based on luminal and basal phenotypes

Radiomics in precision oncology: hype or ludum mutante

Managing advanced prostate cancer in the Asia Pacific region: “Real‐world” application of Advanced Prostate Cancer Consensus Conference 2019 statements

Financial toxicities of cancer in low‐ and middle‐income countries: Perspectives from Southeast Asia

Adolescents and young adults with cancer: Considerations from the Southeast Asian perspective

Identifying Patients With Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma by Plasma Epstein-Barr Virus DNA for Chemotherapy Deintensification: Quo Vadis?

Maintenance Capecitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma—Magic Bullet or Pandora’s Box?

Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial

Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis

Collaborators (2)

Keunchil Park

Daniel E Spratt

Make your next move.